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Background: Rho family GTPases regulate Entamoeba histolytica pathogenesis.
Results:Despite Ras-like structural features and fast intrinsic nucleotide exchange, EhRho1 engages classical Rho effectors and
regulates actin.
Conclusion: EhRho1 is a true Rho family GTPase with a unique mode of nucleotide interaction.
Significance: Possibly representing an early Rho subfamily divergence from the Ras superfamily, EhRho1 likely regulates actin
polymerization in E. histolytica.
The single-celled human parasite Entamoeba histolytica pos-
sesses a dynamic actin cytoskeleton vital for its intestinal and
systemic pathogenicity. The E. histolytica genome encodes sev-
eral Rho family GTPases known to regulate cytoskeletal dynam-
ics. EhRho1, the first familymember identified,was reported tobe
insensitive to the Rho GTPase-specificClostridium botulinumC3
exoenzyme, raising thepossibility that itmaybeamisclassifiedRas
familymember.Here,wereport thecrystal structuresofEhRho1 in
both active and inactive states. EhRho1 is activated by a conserved
switchmechanism, but diverges frommammalianRhoGTPases in
lacking a signature Rho insert helix. EhRho1 engages a homolog of
mDia, EhFormin1, suggesting a role in mediating serum-stimu-
lated actin reorganization and microtubule formation during
mitosis. EhRho1, but not a constitutively active mutant, interacts
with a newly identified EhRhoGDI in a prenylation-dependent
manner. Furthermore, constitutively active EhRho1 induces actin
stress fiber formation in mammalian fibroblasts, thereby identify-
ing itasa functionalRhofamilyGTPase.EhRho1exhibitsa fast rate
ofnucleotideexchangerelative tomammalianRhoGTPasesdue to
a distinctive switch one isoleucine residue reminiscent of the con-
stitutively active F28L mutation in human Cdc42, which for the
latter protein, is sufficient for cellular transformation. Noncon-
served,nucleotide-interactingresidueswithinEhRho1, revealedby
the crystal structuremodels,were observed to contribute amoder-
ating influence on fast spontaneous nucleotide exchange. Collec-
tively, these observations indicate thatEhRho1 is abona fidemem-
ber of the Rho GTPase family, albeit with unique structural and
functional aspects compared withmammalian RhoGTPases.
The parasite Entamoeba histolytica is the causative agent of
amoebiasis in humans, responsible for an estimated 50 million
infections and 100,000 deaths per year worldwide (1). Spread pri-
marily by contaminated drinking water in its encysted form, E.
histolytica infection is endemic among poor populations of devel-
oping countries, although outbreaks and infection among travel-
ers occur frequently in the United States (2). The water-
borne pathogen can attach and invade intestinal mucosa to
cause amoebic colitis, and can also enter the bloodstream,
leading to systemic amoebiasis characterized by liver, lung,
and brain abscesses (3). E. histolytica trophozoites are highly
motile and undergo complex, dynamic cytoskeletal rear-
rangements (4). Indeed, the cytoskeletal dynamics of E. his-
tolytica are vital for many of its pathogenic processes,
including chemotaxis and invasion, adhesion to intestinal
epithelia, phagocytosis, and host cell killing (5).
Rho family GTPases are small guanine nucleotide-binding
proteins of the Ras small G-protein superfamily (6) that pro-
duce multiple effects in cells when activated. The most promi-
nent and immediate effect of Rho activation is actin cytoskeletal
reorganization (7). Rho GTPases are molecular switches, with
an activeGTP-bound state and an inactiveGDP-bound confor-
mation. Conformational shifts in response to nucleotide
exchange are dominated by two conserved switch regions that
contribute to nucleotide state-selective engagement ofmultiple
Rho-interacting proteins (8). Switch 1 contains a highly con-
served phenylalanine that forms aromatic interactions with the
nucleotide guanine ring (9). Rho GTPases are regulated by the
actions of guanine nucleotide exchange factors (GEFs),5
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GTPase activating proteins, and guanine nucleotide dissocia-
tion inhibitors (GDIs) (10). RhoGDIs preferentially bind inac-
tive, GDP-bound Rho GTPases and are critical for shuttling
them between cellular membranes (11). Among the many
effectors of activated human Rho GTPases is mDia, a formin
protein that produces actin filaments by initiating nucle-
ation and polymerization (12).
The genomeofE. histolytica encodes a family of small G-pro-
teins with high sequence similarity to mammalian Rho
GTPases (13, 14). In fact, a remarkably large Rho family of at
least 19 members is simultaneously expressed in E. histolytica
trophozoites (supplemental Fig. S1). Although studies are lim-
ited, certainE. histolyticaRho familyGTPases have been shown
to regulate its actin cytoskeletal dynamics, which are in turn
linked to pathogenic processes. Overexpression of a constitu-
tively active point mutant of the GTPase EhRacA in E. histo-
lytica leads to altered phagocytic activity and surface receptor
capping, a phenomenon vital for evasion of the host immune
response (15). Overexpression of EhRacG alters membrane
turnover, uroid formation, and surface receptor capping (16).
Not surprisingly, Rho-activating GEFs have also emerged as
critical players in E. histolytica pathogenesis (17, 18). Similarly,
E. histolytica possesses homologs to key Rho GTPase effectors,
such as p21-activated kinase and Diaphanous-like formins (19,
20). Although none of the formin family members have been
shown to interact with Rho GTPases from E. histolytica, three
of them (EhFormin1–3) contain RhoGTPase-binding domains
(GBDs), suggesting that they serve as a link between Rho
GTPase activation and actin polymerization. Interestingly,
overexpression of EhFormin1 in E. histolytica trophozoites
revealed its co-localization with actin assemblies promoted by
serum factors, association with microtubules during mitosis,
and aberration of cell division (20).
As the first identified (13) and highly expressed Rho GTPase
family member in E. histolytica (supplemental Fig. S1), EhRho1
serves as an exemplary small G-protein signaling molecule
from E. histolytica. Protein sequence and biochemical analyses
have suggested divergent guanine nucleotide binding motifs
and a resistance to inhibitory ADP-ribosylation by Clostridium
botulinum C3 exoenzyme, a hallmark of mammalian Rho
GTPases (21). Thus, Godbold et al. (21) have suggested that
EhRho1may be a Ras-like GTPase rather than a true functional
ortholog of mammalian Rho GTPases. In the current study, we
have resolved this functional categorization of EhRho1 via
structural models of EhRho1 in two nucleotide states, obtained
by x-ray diffraction crystallography. EhRho1 possesses both
Rho- and Ras-like structural features. Although possessing a
conserved structural mode of activation with mammalian
G-proteins, multiple divergent residues in the nucleotide-bind-
ing pocket were seen to contribute to a fast basal exchange rate
relative to mammalian Rho GTPases. EhRho1 binds to
EhFormin1 and to a novel EhRhoGDI in a nucleotide-depen-
dent fashion. Finally, expression of constitutively active
EhRho1 in mammalian cells induces stress fiber formation,
implicating EhRho1 in the regulation of actin cytoskeletal
dynamics in E. histolytica.
EXPERIMENTAL PROCEDURES
Bioinformatic Analysis of the E. histolytica Rho GTPase
Family—To identify Rho GTPase genes in the sequenced
genome of E. histolytica (22) the amino acid sequence of
EhRho1 (GenBank accession number XP_654488.2) was used
as a template for a sequence similarity search in the NCBI data-
base with the BLAST algorithm (23). Resultant candidate Rho
proteins and associated transcripts were located in the publicly
availablemicroarray data (24). An average expression unit value
was calculated for each transcript using replicate data for
unperturbed E. histolyticaHM1:IMSS trophozoites. Rho genes
that showed 3 expression units (considered to be not
expressed based on a frequency distribution of all transcripts
(supplemental Fig. S1)) and protein sequences that were 80%
identical to another E. histolytica Rho GTPase were excluded
from further analysis to avoid inclusion of closely related iso-
forms and potential microarray probe cross-reactivity. The
remaining 19 RhoGTPase protein sequences were aligned with
ClustalW2 (25) and a dendrogram was generated with NJPlot
(26). Relative expression levels were assigned to each Rho
GTPase transcript based upon a frequency distribution of all
genes included on the microarray platform versus relative
expression unit values (supplemental Fig. S1).
Protein Expression and Purification—Open reading frames
of Ehrho1 lacking the C-terminal CAAX prenylation motif and
its preceding polybasic region (amino acids 1–191), Ehracg,
Ehrhogdi (UniProt identifier O76754), and the Ehformin1
GBD-FH3 domains (amino acids 69–445) were separately
amplified from E. histolytica genomic DNA (obtained fromDr.
William Petri Jr., University of Virginia, Charlottesville, VA) by
polymerase chain reaction (PCR) using Phusion polymerase
(New England BioLabs, Ipswich, MA) and primers from Invit-
rogen (Ehrho1 (amino acids 1–191): sense, 5-ATGCTTGCA-
TTTTCTGATATGAAC-3, antisense 5-CTAATTTGAGA-
AGATACAATC-3; Ehracg: sense, 5-ATGAGACCAGTG-
AAACTTGTC-3, antisense, 5-CTATTTAGCAGCTTTAG-
CAAGAAC-3; Ehrhogdi: sense, 5-ATGTCAGCAGCAGAC-
ATTGTTAAAAAC-3, antisense, 5-TTAATCCCAATCCT-
TGGC-3; and Ehformin1: sense, 5-ATGCCACCTGAA-
GAAGTTG-3, antisense, 5-CTAAGTGACTTGAAGAGA-
TATTTGC-3. PCR amplicons were resolved on, and extracted
from, a 1% (w/v) agarose gel using the Qiagen Gel Extraction
Kit. All three amplicons were subcloned using ligation-inde-
pendent cloning (27) into a Novagen (San Diego, CA) pET vec-
tor-based prokaryotic expression construct (“pET-His LIC-C”
or “pET-GST LIC-C”) to form N-terminal tobacco etch virus
protease-cleavable, His6- or GST-tagged fusions. Point muta-
tions to Ehrho1 and Hs RHOA were made using PCR and the
overlap extension method (28). Clones of human RHOA and
mouse mDia1 were a kind gift from Dr. John Sondek (Univer-
sity of North Carolina, Chapel Hill, NC).
For expression of His6-tagged EhRho1, EhRacG, Hs RhoA,
mDia1 (amino acids 69–450), and EhFormin1 andGST-tagged
RhoGDI, BL21(DE3) Escherichia coliwere grown to an A600 nm
of 0.8 at 37 °C, followed by induction with 500 M isopropyl
-D-thiogalactopyranoside for 14–16 h at 20 °C. Bacterial cells
were pelleted by centrifugation and resuspended in N1 buffer
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composed of 50 mM Tris, pH 7.5, 250 mMNaCl, 10 mM imidaz-
ole, 1 mM DTT, 5% (v/v) glycerol, and for Rho GTPases, 5 mM
MgCl2 and 50 M GDP. Bacteria were lysed at 10,000 kilopas-
cals using pressure homogenization with an Emulsiflex (Aves-
tin; Ottawa, Canada). Cellular lysates containing His6-tagged
proteins were cleared with centrifugation at 100,000  g for 60
min at 4 °C, and the resulting supernatant was applied to a nick-
el-nitrilotriacetic acid resin FPLC column (FF HisTrap crude;
GE Healthcare, Piscataway, NJ), washed with N1 plus 30 mM
imidazole before elution in N1 buffer with 300 mM imidazole.
Lysates containing GST-tagged proteins were applied to a glu-
tathione resin (FF GSTrap; GE Healthcare), washed with N1
buffer lacking imidazole, and eluted with imidazole-free N1
supplemented with 10 mM reduced glutathione. For GST-
RhoGDI, His6-EhFormin1, andHis6-mDia1, eluted proteinwas
pooled and resolved using a calibrated size exclusion column
(HiLoad 16/60 Superdex 200, GEHealthcare) in S200 buffer (50
mMHEPES, pH8.0, 250mMNaCl, 2.5% (v/v) glycerol, and 1mM
DTT). For the Rho GTPases, protein was pooled and dialyzed
into imidazole-free N1 overnight at 4 °C in the presence of
His6-tobacco etch virus protease to cleave theN-terminal affin-
ity tag. The dialysate was then passed over a second nitrilotri-
acetic acid column to remove tobacco etch virus protease and
uncleaved protein. For exchange assays, Rho GTPases were
resolved by size exclusion in Rho S200 buffer (50 mM Tris, pH
8.0, 200 mM NaCl, 10 mM MgCl2, and 5% (v/v) glycerol). For
crystallization, EhRho1 was loaded with either GDP or GTPS
by incubation in EDTA-containing exchange buffer (50 mM
Tris, pH 7.5, 250 mM NaCl, 5 mM DTT, 15 mM EDTA, and
10-foldmolar excess of either GDP orGTPS) at room temper-
ature for 45 min, followed by addition of excess nucleotide-
stabilizing magnesium ion (50 mM MgCl2). Nucleotide-loaded
EhRho1was then resolved by size exclusion chromatography in
crystallization buffer (50 mM Tris, pH 8.0, 250 mM NaCl, 1 mM
MgCl2, 5 mMDTT, and either 50 MGDP or 5 MGTPS). All
proteins were concentrated to 0.5–2 mM and snap frozen in a
dry ice/ethanol bath for storage at 80 °C. Protein concentra-
tion was determined by A280 nm measurements upon denatur-
ation in 8 M guanidine hydrochloride, based on predicted
extinction coefficients for each protein (ExPASy).
Crystallization of EhRho1GDP and EhRho1GTPS and
StructureDetermination—Crystals of EhRho1 (residues 1–191)
bound to GDP were obtained by vapor diffusion from hanging
drops at 18 °C. EhRho1GDP at 15 mg/ml in crystallization
buffer wasmixed 1:1 with (and equilibrated against) crystalliza-
tion solution containing 1.5 M ammonium sulfate and 100 mM
Tris, pH 8.0. Rhomboidal crystals grew to 200  100  100
m over 5 days, exhibiting the symmetry of space group
P212121 (a  50.3 Å, b  54.5 Å, c  132.3 Å,       90°)
and containing twomonomers in the asymmetric unit. For data
collection at 100K, crystals were serially transferred for1min
into crystallization solution supplemented with 25% (v/v) glyc-
erol in 5% increments and plunged into liquid nitrogen. A
native data set was collected at the SER-CAT 22-ID beamline at
the Advanced Photon Source (Argonne National Laboratory).
Data were processed using the HKL-2000 program (29). The
crystal structure model of human RhoAGDP (PDB accession
1FTN (9)) was modified by removal of water, magnesium, and
nucleotide and by trimming the side chains not conserved in
EhRho1 using Chainsaw (30). The resulting model was used as
a molecular replacement search model in the program Phaser
(31). Refinement was carried out using phenix.refine (32) inter-
spersed with manual revisions of the model using the program
Coot (33). Refinement consisted of conjugate-gradientminimi-
zation and calculation of individual anisotropic displacement
and translation/libration/screw parameters (34). The current
model contains two EhRho1 monomers bound to GDP and
magnesium; residues at the N and C termini (1–14 for both
chains and 187–194 for chain A) could not be located in the
electron density.
Crystals of EhRho1 bound to GTPS were obtained by vapor
diffusion from hanging drops at 18 °C. EhRho1GTPS at 14
mg/ml in crystallization buffer was mixed 1:1 with (and equili-
brated against) crystallization solution containing 25% PEG
4000, 150mM ammonium acetate, and 100mM sodium acetate,
pH 4.6. Rod crystals grew to 200  75  50 mm over 3 days
and exhibited the symmetry of space group P1 (a  36.4 Å, b 
39.5 Å, c  63.6 Å,   81.8°,   80.8°,   65.4°) with two
monomers in the asymmetric unit. For data collection at 100 K,
crystals were serially transferred for 30 s into crystallization
solution supplemented with 30% saturated sucrose in 10%
increments and plunged into liquid nitrogen. A native data set
was collected at the SER-CAT 22-BM beamline at the
Advanced Photon Source (ArgonneNational Laboratory). Data
processing and refinement were carried out similarly to
EhRho1GDP, as described above. However, a molecular
replacement solution was obtained using the crystal structure
model of human RhoA bound to GTPS (PDB accession 1A2B
(35)) modified to exclude water, magnesium, nucleotide, and
nonconserved side chain atoms. The current model contains
two EhRho1 monomers bound to GTPS and magnesium; res-
idues at theNandC termini (1–20 and 192–194 for chainA and
1–20 and 189–194 for chain B) could not be located in the
electron density. Despite low diffraction data completeness in
high resolution shells for EhRho1GTPS, strong electron den-
sity arose for GTPS and missing side chains upon molecular
replacement solution and no systematic defects were identified
in the electron density map (see supplemental Fig. S2). To
ensure model accuracy, the diffraction data were processed in
parallel with a 2.5-Å resolution cutoff, producing a model with
no observed differences from the high-resolution inclusive
data. However, inclusion of the less complete, high resolution
data (2.5–1.8 Å) substantially increased electron density qual-
ity. For data collection and refinement statistics, see Table 1. All
structural images were rendered with PyMOL (Schrödinger
LLC, Portland, OR) unless otherwise indicated.
Surface Plasmon Resonance Binding Assays—Surface plas-
mon resonance-based measurements of protein-protein inter-
actions were performed on a Biacore 3000 (GE Healthcare).
Approximately 8000 resonance units of purified His6-Eh-
Formin1 and 10,000 resonance units of the His6-mDia1 GBD-
FH3 domain tandem were separately immobilized on a nickel-
charged nitrilotriacetic acid biosensor chip (GE Healthcare)
using covalent capture coupling as previously described (36).
An irrelevant His6 protein (Hs Gi1) was loaded on an inde-
pendent surface as a negative control. Surface plasmon reso-
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nance experiments were performed in running buffer contain-
ing 50 mM HEPES, pH 7.4, 150 mM NaCl, 0.05% Nonidet P-40
alternative (Calbiochem), 50 M EDTA, 1mMMgCl2, and 5 M
of either GDP or GTPS. Thirty-l injections of increasing
concentrations of GDP- or GTPS-loaded EhRho1, EhRacG,
and Hs RhoA were separately performed at 10 l/min with a
300-s dissociation phase (using the KINJECT command). The
surface was regenerated between Rho GTPase injections by
injection of running buffer supplemented with 30 mM EDTA.
To correct for nonspecific binding and changes in the refractive
index upon injection of samples, the observed sensorgram for
the flow cell containing the irrelevant protein Hs Gi1 was sub-
tracted from all curves using BIAevaluation software version
3.0 (GE Healthcare). Equilibrium binding analyses were con-
ducted as previously described (37) using GraphPad Prism ver-
sion 5.0 to determine binding affinities.
GST-EhRhoGDI Affinity Co-precipitation—The full-length
Ehrho1 gene was synthesized following codon optimization for
expression in mammalian cells (GeneArt, Invitrogen). Ehrho1
and mutants were subcloned with an HA epitope tag into
pcDNA 3.1 and transfected into HEK293T cells using Lipo-
fectamine 2000 (Invitrogen), 1g of DNA per 6-well dish. Cells
expressing wild-type or mutant EhRho1 were lysed in buffer
containing 20 mM Tris, pH 7.5, 100 mM NaCl, 1 mM MgCl2, 1%
(v/v) Nonidet P-40, 0.25% (v/v) deoxycholate, and protease
inhibitors. Soluble fractions of the cell lysates were incubated
with 15 g of either recombinant GST-RhoGDI or GST alone
and glutathione-agarose (Sigma) at 4 °C overnight with gentle
agitation. Bound proteins were separated by centrifugation,
washed 3 times with lysis buffer, and eluted with denaturing
SDS-PAGE loading buffer. Proteins/lysates were separated by
SDS-PAGE, transferred to nitrocellulose membranes, and sub-
jected to Western blotting with anti-HA as described previ-
ously (38). Subsequently, membrane-bound proteins were
stained with Ponceau S (Bio-Rad).
Fluorescent Guanine Nucleotide Exchange Assays—The flu-
orescence of BODIPY FL GDP (Invitrogen) was monitored in
real-time using a cuvette-based LS 55 spectrometer (PerkinEl-
mer Life Sciences) under thermostat control. Excitation and
emissionwavelengthswere 502 2.5 and 511 2.5 nm, respec-
tively. Exchange buffer alone (20 mM Tris, pH 7.5, 150 mM
NaCl, 5 mMMgCl2, 2 mM DTT, 5% (v/v) glycerol, 0.008% Non-
idet P-40 alternative, and 75 nM BODIPY FL GDP) was moni-
tored at 15 °C until a stable signal was achieved. At time 0, 400
nM Rho GTPase was added to the cuvette with mixing. The
increase in relative fluorescence of BODIPY FL GDP upon
incorporation into the Rho GTPase nucleotide-binding pocket
wasmonitored at 30-s intervals for 100min. Because saturation
exchange was not reached due to the characteristically slow
release ofGDP fromRhoGTPases in the absence ofGEF, 30mM
EDTA was added to the cuvette at the end of each time course,
inducing rapid exchange; the fluorescence intensity after equil-
ibration with excess EDTAwas thus defined as 100% exchange.
Each curve was fitted with an exponential association function
to yield a rate constant, kobs, using GraphPad Prism version 5.0.
Actin Stress Fiber Quantification—Rat-2 fibroblasts were
transfected with HA-tagged constitutively active human
RhoA(G14V), EhRho1(Q78L), or empty vector control
(pcDNA3.1) and plated onto fibronectin-coated coverslips (15
g/ml) overnight. Transfection efficiency was 80–90%. Cells
were fixed in 3.7% paraformaldehyde and permeablized with
0.02% (v/v) Triton X-100. F-actin structures were stained with
Texas Red phalloidin (Molecular Probes) and exogenously
expressed Rho GTPases were visualized using anti-HA immu-
nofluorescence. To quantify stress fibers, HA-positive cells
were scored by a blinded observer for the presence or absence of
stress fibers, with the criteria being: organized, thickened, par-
allel actin bundles throughout the majority of the cytoplasm.
Results are plotted as percent of cells positive for stress fiber
phenotype, scoring 200 cells from many fields in duplicate
experiments. Statistical significance was determined by Stu-
dent’s t test.
RESULTS
Comparison of Human and E. histolytica Ras Superfamily
GTPases—EhRho1 (GenBank accession no. XP_654488.2) is
most similar to RhoA (Uniprot P61586) among the human Ras
superfamily ofGTPases. Sequence identity of only 47%between
these two proteins likely reflects unique features gained or lost
across a relatively large evolutionary distance. A multiple
sequence alignment of Rho and Ras family GTPases from E.
histolytica and humans (Fig. 1) identified unique and conserved
residues in EhRho1. EhRho1 displays a conserved cysteine at
position 35, which has been implicated as an important site for
reactive oxygen and nitrogen species-mediated activation of
human Rho GTPases (39). Switch 2 is remarkably conserved
from Entamoeba to humans, but switch 1 diverges across spe-
cies. Notably, EhRho1 displays an isoleucine at position 45 in
place of the otherwise highly conserved, nucleotide-contacting
phenylalanine. Mutation of the analogous residue in human
Rho GTPases results in 100-fold faster nucleotide exchange
thanwild-type in the absence of a GEF, resulting in constitutive
activity (40). In fact, the corresponding mutation in Hs Cdc42,
F28L, can induce cellular transformation in fibroblasts (41).
This unique residue has led others to postulate that EhRho1 is
constitutively active (21). Two other putative nucleotide-con-
tacting residues in EhRho1 differ from the Rho/Ras consensus,
namely, Ser-166 and Val-167. These sequence features of
EhRho1 taken together have suggested a unique mechanism of
nucleotide exchange and thus activation (21). To investigate
the structural determinants of EhRho1 activation, we obtained
high-resolution structural models of EhRho1 in two nucleotide
states by x-ray diffraction crystallography.
Structures of EhRho1 in the Active and Inactive States—Be-
cause Rho GTPases possess a conserved C-terminal prenyla-
tion site, the CAAX box, and an adjacent polybasic region that
are not typically well ordered in a crystalline state, we crystal-
lized a truncated form of EhRho1 (residues 1–191) bound to a
divalent magnesium ion and either GDP or the nonhydrolyz-
able GTP analog, GTPS. Both forms of EhRho1 produced well
diffracting crystals, with diffraction data extending to 1.95- and
1.80-Å resolution, respectively. Structural statistics of both
complexes are listed in Table 1. Phases were resolved bymolec-
ular replacement using the crystal structure models of human
RhoA bound to GDP (9) and GTPS (35), respectively (PDB
codes 1FTN and 1A2B).
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FIGURE 1. Sequence similarity among Rho and Ras family GTPases from E. histolytica and humans. A, a multiple sequence alignment highlights conserved
switch regions and nucleotide-interacting residues (closed circles) derived from the crystal structures of EhRho1 reported here. The characteristic Rho insert
helix region is indicated in gray, and arrowheads mark residues mutated in this study. B, purified Rho GTPases and the tandem Rho GBD and FH3 domains of
EhFormin1 (residues 69 – 445) were resolved by SDS-PAGE and stained with Coomassie Blue. EhFormin1 GBD-FH3 was co-purified with a likely C terminus
truncated form (asterisk).
TABLE 1
Data collection and refinement statistics
EhRho1GDPa EhRho1GTPS
PDB accession code 3REF 3REG
Data collection
Space group P212121 P1
Unit cell
a, b, c (Å) 50.3, 54.5, 132.3 36.5, 39.5, 63.6
, ,  (°) 90, 90, 90 81.8, 80.8, 65.4
Resolution (Å) 30.0–1.95 (1.98–1.95) 40.0–1.80 (1.82–1.80)
Rsym 0.047 (0.187) 0.043 (0.278)
I/I 21.9 (2.7) 16.1 (2.8)
Unique reflections 27,267 (633) 23,929 (435)
Completeness (%) 99.6 (99.4) 81.6 (45.9)b
Redundancy 2.5 (1.7) 2.0 (1.4)
Wilson B-factor (Å2) 23.0 21.6
Refinement
Resolution (Å) 28.3–1.95 (2.01–1.95) 33.0–1.80 (1.87–1.80)
No. of reflections (work/free) 27,160/1366 (2,660/123) 23,884/1,214 (1,558/86)
Cut-off (s) 0.12 0











Root mean square deviations
Bond lengths (Å) 0.009 0.009
Bond angles (°) 1.26 1.20
Ramachandran
Favored (%) 95.7 98.5
Generally allowed (%) 4.3 1.5
Disallowed (%) 0 0
Missing residues A: 1–14, 188–194 A: 1–20, 192–194
B: 1–14 B: 1–20, 189–194
a Values in parentheses represent the highest resolution shell. Diffraction data were generated from single crystals of EhRho1 in each nucleotide state.
b Despite 81.6% completeness of the EhRho1GTPS data set, the resulting electron density was of high quality without systematic deficits (see supplemental Fig. S2).
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EhRho1 exhibits the highly conserved G-domain fold char-
acteristic of Ras superfamily GTPases (10), consisting of a
6-stranded -sheet surrounded by 5 -helices. The core fold of
EhRho1 is similar to that of both human RhoA (PDB 1A2B) and
H-Ras (PDB 5P21), with total C root mean square deviation
values of 1.1 and 2.0 Å, respectively. Superposition of the two
EhRho1 conformations (Fig. 2A) highlights switch regions 1
and 2 as the most mobile areas associated with activation. The
switch 1 loop is drawn closer to the nucleotide in the GTPS-
bound form than when bound to GDP, and the N-terminal
portion of switch 2 rearranges upon binding GTPS due to
polar contacts with the -phosphoryl group.
The switch regions of both monomers in the EhRho1GDP
structural model formminimal crystal contacts with neighbor-
ingmolecules. OnlyGlu-80 on switch 2 of chainA forms a polar
contact with a neighboring molecule. Chain B switch residues
Tyr-49, Thr-55, and Tyr-81 also form hydrogen bonds with
residues of another asymmetric unit. Despite these differing
crystal contacts, both EhRho1GDP monomers display switch
conformations distinct from those of EhRho1GTPS, indicat-
ing that the observed switch conformation shift is not likely due
to crystal packing.
The crystal structures of EhRho1 also revealed the absence of
a signature Rho insert helix in the 5-4 loop, a key feature
conserved among all other known Rho family GTPases (Fig. 2)
(9, 42). Instead, the 5-4 loop lacks uniform secondary struc-
ture, as seen in Ras family GTPases (43). The insert helix is not
vital for the interaction of human RhoGTPases with themajor-
ity of interacting partners (44, 45). However, it is required for
some effector interactions, such as Cdc42-mediated activation
of phospholipase D1 (46) and activation of NADPH oxidase by
Rac (47). The absence of an insert helix, in combination with its
insensitivity to the Rho-specificC. botulinumC3 exotoxin (21),
led us to ask whether EhRho1 was actually a misclassified Ras
family GTPase. Accordingly, we looked for interaction of
EhRho1 with E. histolytica homologs of classical effectors.
EhRho1 Interacts with an mDia Homolog, EhFormin1—The
E. histolytica genome encodes a family of eight Formins (20).
EhFormins 1–3 contain a Rho GBD in tandem with a formin
homology 3 (FH3) domain, homologous to mammalian mDia
and Drosophila melanogaster Diaphenous (12). EhFormin1,
also known as EhDia, is known to regulate actin polymerization
and cell cycle progress in E. histolytica trophozoites (20). We
cloned and purified the GBD-FH3 tandem of EhFormin1 (Fig.
1B) and used surface plasmon resonance to quantify binding to
EhRho1 in each nucleotide state. EhFormin1 was observed to
selectively bind EhRho1 (KD  1.7  0.1 M), but not the
related GTPase EhRacG (Fig. 3). The interaction was depen-
dent on the nucleotide state of EhRho1 (Fig. 3B), char-
acteristic of a GTPase/effector interaction. The affinity of
EhRho1GTPS/EhFormin1 was an order of magnitude lower
than that observed for Hs RhoAGppNHp/mDia1 (KD  104 
37 nM) under identical conditions (Fig. 3, C and D). However,
this low micromolar affinity EhRho1/EhFormin1 interaction is
likely relevant in a cellular context, given the observed stringent
nucleotide state selectivity and previous evidence for colocal-
ization of both proteins in the E. histolytica uropod (48). We
conclude that EhRho1 engages similar effectors to mammalian
Rho family GTPases.
EhRho1 Interacts with aNewly Identified RhoGDI—RhoGDIs
maintain a pool of soluble, inactive Rho GTPases by extracting
prenylated GTPases from cellular membranes (11). The E. his-
tolytica genome encodes a single gene with a conserved
RhoGDI domain, which we refer to as EhRhoGDI (UniProt
identifier O76754). We cloned and purified EhRhoGDI as a
FIGURE 2. The structural models of EhRho1 in two nucleotide states
reveal a conserved mechanism of nucleotide-dependent activation with
Rho- and Ras-like characteristics. A, models of the crystal structures of
EhRho1 bound to magnesium and GDP (red) or the nonhydrolyzable GTP
analog GTPS (green) are superimposed. See Table 1 for crystallographic data
collection and refinement statistics. GTPS is modeled as blue sticks, and mag-
nesium as a yellow sphere. The well conserved switch regions, shown in light
shades, account for the majority of nucleotide state-dependent conforma-
tional shifts. EhRho1 is seen to lack the signature Rho insert helix found on all
members of the mammalian Rho GTPase family, represented by human RhoA
(B), with the insert in yellow (PDB accession 1A2B). Instead, EhRho1 shares a
nonhelical 5-4 loop with Ras GTPases, represented by human H-Ras (C)
(PDB accession 5P21). GppNHp, guanosine 5-(,-imido)triphosphate.
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GST fusion and used the recombinant protein to co-precipitate
EhRho1 expressed in HEK293T cells (Fig. 4). Mammalian
RhoGDIs contain a geranylgeranyl-binding pocket and favor
binding to the inactive, GDP-bound conformation of Rho
GTPases (11). To examine the nucleotide state selectivity and
Rho prenylation dependence of the EhRho1/EhRhoGDI inter-
action, we compared co-precipitation of a GTPase-deficient,
constitutively active EhRho1 mutant (Q78L) and EhRho1 lack-
ing the putatively prenylated CAAX motif cysteine (C212S) to
that ofwild-type EhRho1.Althoughwild-type EhRho1was seen
to robustly interact withGST-EhRhoGDI in cellular lysates, the
complex was disrupted by either EhRho1 constitutive activity
or mutation of the putative prenylation site (Fig. 4B). Consis-
tent with a requirement for prenylation of EhRho1 to engage
EhRhoGDI, we also did not observe binding between GST-Eh-
RhoGDI and C terminally truncated EhRho1 produced recom-
binantly from E. coli (not shown).
EhRho1 Stimulates Stress Fiber Formation in Mammalian
Cells—One of the most prominent and immediate effects of
human RhoA activation in fibroblasts is the formation of fila-
mentous actin bundles known as stress fibers (7). To determine
the behavior of EhRho1 in a cellular context, we expressed
GTPase-deficient, constitutively active EhRho1(Q78L) or con-
stitutively active human RhoA in Rat-2 cells and examined
stress fiber formation with phalloidin staining. Both constitu-
tively active EhRho1 and Hs RhoA expression significantly
induced stress fiber formation compared with mock-trans-
fected Rat-2 cells (Fig. 5). Thus, EhRho1 modulates cellular
actin structures, likely through signaling pathways similar to
human RhoA. These findings, together with EhRho1 interac-
tion with the canonical effectors EhFormin1 and EhRhoGDI,
imply that EhRho1 functions as true Rho family members,
despite its Ras-like lack of an insert helix (Fig. 2) and insensitiv-
ity to the Rho-specific C3 exoenzyme (21).
FIGURE 3. EhRho1 interacts with EhFormin1, a homolog of the human Rho effector mDia. A, the GBD-FH3 tandem of EhFormin1, also referred to as EhDia,
was observed to bind EhRho1GTPS selectively (to the exclusion of EhRacGGTPS), as determined by surface plasmon resonance. B, injection of increasing
amounts of GTPase over immobilized EhFormin1 revealed specific binding to the activated form of EhRho1 with low micromolar affinity. C and D, the
homologous interaction between Hs RhoA and mouse mDia1 GBD-FH3 tandem was also highly nucleotide state-selective, with high nanomolar affinity.
GppNHp, guanosine 5-(,-imido)triphosphate.
FIGURE 4. EhRho1 interaction with EhRhoGDI is favored by the inactive
conformation and prenylation at the CAAX motif. A, EhRhoGDI was cloned
from the E. histolytica genome and purified as a GST fusion from E. coli. Puri-
fied GSTEhRhoGDI was resolved by SDS-PAGE and stained with Coomassie
Blue. B, HA epitope-tagged EhRho1 expressed in HEK293T cells co-precipi-
tated with GST-RhoGDI immobilized on glutathione-agarose, but not GST
alone, as indicated by immunoblotting with anti-HA antibody. The EhRho1/
EhRhoGDI interaction was disrupted by mutation of the key glutamine for
GTP hydrolysis (Q78L), rendering EhRho1 constitutively active. In addition,
mutation of the CAAX motif cysteine that is geranylgeranylated in mamma-
lian Rho GTPases (C212S in EhRho1) abolished binding to EhRhoGDI.
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Unique Nucleotide Interactions in EhRho1—A structure-
based multiple sequence alignment of EhRho1 with mamma-
lian Rho GTPases (Fig. 1A) revealed a potentially activating
Ile-45 in the position occupied by a conserved phenylalanine in
all other Rho GTPases (Phe-28 in Cdc42). Additionally, the
nonconserved Ser-166 and Val-167 of EhRho1 replace residues
of Rho GTPases that contact the guanine ring of GDP/GTP (9),
suggesting a unique mechanism of nucleotide binding and
exchange. The electron density map of the EhRho1GDP com-
plex shows clearly defined backbone and side chains surround-
ing the bound nucleotide (Fig. 6A), affording a detailed analysis
of nucleotide contacts.
The aromatic side chain of Phe-30 of Hs RhoA makes -or-
bital interactions with the guanine ring of GDP (Fig. 6B) (49),
and similar contacts are seen in HsCdc42 and Hs Rac (49, 50).
Mutation of this phenylalanine to leucine in each Rho family
GTPase results in markedly faster basal nucleotide exchange
(40) (Fig. 7) and increased disorder in switch 1, presumably
allowing an easier exit route for GDP (49). In contrast, switch 1
of EhRho1GDP is well defined in the crystal structure with
continuous, strong electron density (Fig. 6A), despite substitu-
tion of a nonaromatic hydrophobic side chain at position 45.
The “top” face of the GDP guanine ring forms Van der Waals
interactions with the hydrophobic portion of Lys-133 in an
identical fashion toHs RhoA (Fig. 6). Also conserved is a hydro-
gen bond network between Asp-135 and the 2-amino and
6-keto groups of the guanine ring. However, the residue triad in
positions 165–167, Ser-Ser-Val of EhRho1, differs from the
conserved Ser-Ala-Lys/Leu of other Rho GTPases (Fig. 1A).
Because the switch 1 phenylalanine side chain (typically avail-
able to form aromatic contacts with the “bottom” face of the
guanine ring) is replaced by Ile-45 in EhRho1, we hypothesized
that other nonconserved residues (Ser-166 and Val-167) may
compensate to control the rate of spontaneous nucleotide
exchange. Ser-166 is clearly defined in the electron density and
does not engage the nucleotide through its side chain.However,
an alternate Ser-166 rotamer could easily bring the noncon-
served hydroxyl groupwithin hydrogen bonding distance of the
6-keto or N7 position of the guanine ring, thus restraining the
nucleotide. Similarly, the bulky hydrophobic side chain of Val-
167 may serve to engage the guanine ring opposite Lys-133 to
stabilize nucleotide binding. To address these hypotheses, we
sequentiallymutated these EhRho1 residues to the correspond-
ing Hs RhoA side chains and tested their effects on guanine
nucleotide exchange.
Nonconserved Residues in EhRho1 Contribute to a Restrained
Nucleotide Exchange Rate—The intrinsic rate of nucleotide
exchange onG-proteins can bemonitored in real time by track-
ing the increase in fluorescence of a dye-labeled nucleotide
upon binding into the nucleotide pocket (reviewed in Ref. 51).
The resulting binding curves yield kinetic information about
the nucleotide exchange reaction, with the rate-limiting step
being the release of tightly bound nucleotide. We first exam-
ined the basal exchange rates of EhRho1 andHs RhoA to deter-
mine whether EhRho1 is constitutively active, given its isoleu-
cine at position 45. EhRho1 was found to exchange nucleotide
more quickly than Hs RhoA (and other human Rho GTPases
(40)), with an4-fold higher kobs (Fig. 7A). However, the rate of
exchange of EhRho1 is not comparable with the constitutively
activating F30L Hs RhoA mutant, which exhibits a 20-fold
faster exchange than wild-type Hs RhoA and saturation within
a fewminutes. We reasoned that EhRho1 must have additional
mode(s) of nucleotide retention, potentially through noncon-
served residues Ser-166 and Val-167 (Fig. 6A), as previously
described. Substitution of both residues for the analogous Hs
RhoA residues (S116A/V167K) increased the exchange rate an
additional 2-fold over wild-type EhRho1, implicating these
two residues as important for maintaining a controlled
exchange rate despite the presence of Ile-45 on switch 1 (Fig.
6A). However, the EhRho1 S166A/V167K mutant still
exchanged only 8-fold faster than wild-type Hs RhoA, imply-
ing other controlling mechanisms in EhRho1 that are not pres-
ent in the extremely fast-exchanging Hs RhoA F30L mutant
(40).
Finally, we asked whether the additional methyl group of
isoleucine 45 relative to leucine might contribute to the con-
trolled nucleotide exchange of EhRho1 compared with Hs
RhoA F30L. Mutation of Ile-45 to leucine increased the rate of
exchange 2-fold, comparable with the RhoA-like S166A/
V167K double mutation (Fig. 7B). Interestingly, insertion of a
phenylalanine at this position (the conserved residue among
other Rho GTPases) drastically dampened the fast EhRho1
FIGURE 5. EhRho1 induces stress fiber formation in mammalian fibro-
blasts. Rat-2 fibroblasts were transfected with either pcDNA3.1 (vector con-
trol), HA epitope-tagged constitutively active (CA) human RhoA(G14V), or
EhRho1(Q78L). Following 24 h plating on fibronectin-coated coverslips, the
cells were fixed and stained with phalloidin and anti-HA antibody. Cells were
scored for the presence of actin stress fibers by a blinded observer. A, fibro-
blasts expressing either constitutively active Hs RhoA or EhRho1 had a signif-
icantly greater percentage of cells with actin stress fibers compared with vec-
tor control. Error bars represent S.E. for duplicate experiments, and * indicates
p  0.01 compared with vector control. B, representative phalloidin staining
(upper panels) and anti-HA antibody immunofluorescence (lower panels)
images indicate more prominent stress fibers in constitutively active Hs
RhoA- and EhRho1-expressing cells compared with vector control. The scale
bar represents 50 m.
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exchange rate; EhRho1 I45F exhibited exchange indistinguish-
able from wild-type Hs RhoA (Fig. 7B). In conclusion, Ile-45 of
EhRho1 is sufficient to confer 4-fold faster exchange over
other known Rho GTPases, without resulting in an uncon-
trolled, constitutively active G-protein as seen in Phe 3 Leu
mutations of human Rho GTPases.
DISCUSSION
The genome of the single-cell protist E. histolytica encodes a
strikingly large family of expressed Rho GTPases (19 members
in E. histolytica versus 20 in humans) (supplemental Fig. S1),
given the relative simplicity of a unicellular parasite compared
with the diverse array of cell and tissue types in mammals.
Mammalian Rho GTPases are known to have a complex chore-
ography of spatiotemporal regulation of multiple family mem-
bers within a single cell during such processes as cell migration
(e.g. Ref. 52). Amoeboid motility is also complex, although
poorly understood, and requires membrane detachment from
cytoskeletal components (blebbing) and rapid subsequent
restructuring of actin (53). In addition to motility, E. histolytica
is dependent on a dynamic actin cytoskeleton formultiple path-
ogenic processes such as attachment, destruction, and phago-
cytosis of host cells, chemotaxis, and shedding of host antibod-
ies from the cell membrane (4, 54). To begin to understand the
E. histolytica Rho family GTPases role in regulating these pro-
cesses via nucleotide cycling, we have now provided structural
snapshots of a representative family member, EhRho1, yielding
insights to its mechanisms of nucleotide-dependent activation
and effector engagement. Like its mammalian homologs,
EhRho1 exhibits a conformational change upon exchanging its
bound GDP for a nucleotide bearing a third phosphoryl group,
dominated by mobile two-switch regions. Because the highly
mobile N-terminal portion of switch 2 is uniformly conserved
with the related EhRacG (and others), we hypothesize that
switch 1 plays a dominant role in dictating nucleotide state-
specific binding to EhRho1 effectors, such as EhFormin1. Sur-
prisingly, EhRho1 lacks a signature Rho insert helix, conserved
FIGURE 6. Unique guanine nucleotide binding pocket residues of EhRho1. A, a stereo view of the nucleotide binding pocket from EhRho1GDP illustrates
a divergent set of residues interacting with the guanine ring of GDP (green) when compared with the corresponding region of human RhoA (B) (PDB accession
1FTN). Position 45 on switch 1 is occupied by an isoleucine (Ile-45) in EhRho1, corresponding to Phe-30 in Hs RhoA; the latter residue makes -orbital
interactions with the guanine ring of GDP (55). The conserved triad of Ser-160, Ala-161, and Lys-162 in Hs RhoA is replaced by Ser-165, Ser-166, and Val-157 in
EhRho1. The electron density map was contoured to   3.0.
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among mammalian Rho GTPases, resulting in a secondary
structure patternmore closely akin toH-Ras.AlthoughEhRho1
has the highest sequence similarity to Hs RhoA, we and others
(21) questioned whether it might be misclassified as a Rho
GTPase.
Our present observations of nucleotide-state selective bind-
ing to EhFormin1 and EhRhoGDI, together with stress fiber
induction in mammalian fibroblasts, indicate correct labeling
of EhRho1 as a bona fide Rho GTPase. One may speculate that
EhRho1, in lacking the characteristic Rho insert helix yet bind-
ing to classical Rho GTPase effectors resembles an ancestral
small G-protein family, and thereby represents an early split of
theRhoGTPase subfamily from the greater Ras superfamily (6).
EhFormin1 localizes with actin filaments inE. histolytica tro-
phozoites upon exposure to serum factors (19) and is co-en-
riched with EhRho1 in the uropod, suggesting roles for the
EhRho1EhFormin1 complex in amoebic motility and/or sur-
face receptor capping (48). EhFormin1 also co-localizes with
microtubules during mitosis, and its overexpression leads to
delays in cell cycle progression (20). It will be interesting to
determine whether EhRho1mediates actin and/ormicrotubule
dynamics in response to extracellular cues in E. histolytica tro-
phozoites. Like its mammalian counterparts (10), EhRho1
might also exert control over cell division, either through
EhFormin1 regulation of microtubule structures, or through
other mechanisms such as transcriptional regulation.
Another unique feature of EhRho1 is its relatively fast rate of
spontaneous nucleotide exchange in the absence of an
exchange factor (GEF). Future experiments will determine
whether exchange on EhRho1 ismodulated by EhRhoGDI. The
moderately fast, spontaneous exchange is mediated by three
nonconserved residues surrounding the guanine moiety bind-
ing site. The switch 1 residue Ile-45, reminiscent of the consti-
tutively active Hs Cdc42 F28L mutant (41), is sufficient to
endow EhRho1 with an exchange rate intermediate between a
Rho-like phenylalanine substitution and a rapid exchanging
leucine substitution. In addition, Ser-166 and Val-167 on the
6-5 loop contribute to nucleotide binding stability to a
greater extent than the analogous Ala-161 and Lys-162 in Hs
RhoA. Together, these data suggest that EhRho1 has evolved a
relatively high rate of basal activity through the loss of a highly
conserved switch 1 phenylalanine residue. However, uncon-
trolled exchange and constitutive activity are avoided, in part
through compensatory nucleotide-interacting residues. Inter-
estingly, neither the I45Lmutation nor the S166A/V167K dou-
ble mutation recapitulated the uncontrolled exchange seen in
the Hs RhoA F30L mutation (41). In the crystal structures of
EhRho1, the nucleotide binding pocket is nearly identical to
that of Hs RhoA except for the residues highlighted in this
study. We hypothesize that EhRho1 protein dynamics in solu-
tion, rather than amino acid sequence, may contribute to a
more moderate nucleotide exchange. NMR studies of Cdc42
have identified increased switch 1 mobility upon introduction
of the F28L mutation (55). Because the switch 1 region of
EhRho1 is well ordered in the crystal structures, its conforma-
tional restrictionsmay contribute to relative nucleotide binding
stability.
FIGURE 7. Nonconserved nucleotide binding pocket residues moderate
an otherwise fast rate of nucleotide exchange on EhRho1. A, real-time
measurement of Rho GTPase binding to fluorescent BODIPY-GDP demon-
strated a 4-fold higher spontaneous nucleotide exchange rate on EhRho1
compared with Hs RhoA, representative of the Rho family GTPases in mam-
mals. The Hs RhoA F30L mutant exchanged nucleotides at a 20-fold higher
rate than wild-type Hs RhoA. Substitution of nonconserved guanine ring-
interacting residues Ser-166 and Val-167 of EhRho1 for the corresponding
amino acids from Hs RhoA (Ala and Lys) results in a 2-fold higher rate of
exchange compared with wild-type EhRho1, implicating these residues as
important for limiting basal nucleotide exchange in wild-type EhRho1. B,
Ile-45 in EhRho1 corresponds to the highly conserved Phe-30 of Hs RhoA, of
which mutation to leucine results in very rapid exchange and constitutive
activity (40). Interestingly, the Hs RhoA-like substitution on EhRho1, Ile-45 to
phenylalanine, produces a slow exchange rate, indistinguishable from wild-
type Hs RhoA. Mutation of Ile-45 to leucine produces a 2-fold increase in the
rate of exchange. C, the average exchange rate constants, kobs, derived from
exponential curve fitting were plotted with S.E. (bars) for quadruplicate
experiments. Asterisks indicate statistically significant differences from
EhRho1 wild-type (*, p  0.05; **, p  0.01).
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